tiprankstipranks
Trending News
More News >

Medtronic price target lowered to $101 from $105 at RBC Capital

RBC Capital lowered the firm’s price target on Medtronic (MDT) to $101 from $105 but keeps an Outperform rating on the shares. The company’s initial FY26 EPS view was below estimates, with 4% y/y growth ex-tariffs due to higher rates of investments intended to position Medtronic for future growth, as well as due to the impacts from some below-the-line items, the analyst tells investors in a research note. RBC adds however that there is potential upside to Medtronic’s mid-single-digit organic revenue growth outlook.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue